STOK - Stoke Therapeutics, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Bedford,
United States
Type: Equity
STOK price evolution
STOK
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $192.01 | $190.55 | $192.63 | $190.91 |
| Short term investments | $9.95 | $24.74 | $39.39 | $63.33 |
| Net receivables | $0.06 | $0.1 | $0.14 | $0.49 |
| Inventory | ||||
| Total current assets | $215.34 | $230.02 | $246.23 | $270.24 |
| Long term investments | ||||
| Property, plant & equipment | $12.43 | $9.3 | $10.12 | $10.99 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $13 | $9.87 | $10.69 | $11.56 |
| Total investments | $9.95 | $24.74 | $39.39 | $63.33 |
| Total assets | $228.34 | $239.89 | $256.92 | $281.8 |
| Current liabilities | ||||
| Accounts payable | $1.7 | $3.08 | $1.56 | $4.3 |
| Deferred revenue | $48.38 | $49.47 | $51.32 | $47.59 |
| Short long term debt | ||||
| Total current liabilities | $30.82 | $25.2 | $21.84 | $31.53 |
| Long term debt | ||||
| Total noncurrent liabilities | $37.96 | $41.69 | $44.89 | $36.45 |
| Total debt | ||||
| Total liabilities | $68.78 | $66.89 | $66.72 | $67.97 |
| Shareholders' equity | ||||
| Retained earnings | -$401.85 | -$374.89 | -$350.35 | -$319.69 |
| Other shareholder equity | -$0.02 | -$0.15 | -$0.38 | -$0.6 |
| Total shareholder equity | $159.56 | $173 | $190.19 | $213.82 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $192.01 | $114.13 | $145.46 | $287.51 |
| Short term investments | $9.95 | $116.04 | $74.92 | |
| Net receivables | $0.06 | $0.59 | $0.13 | |
| Inventory | ||||
| Total current assets | $215.34 | $244.07 | $229.22 | $293.93 |
| Long term investments | ||||
| Property, plant & equipment | $12.43 | $11.43 | $9.08 | $3.79 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $13 | $12 | $9.65 | $4 |
| Total investments | $9.95 | $116.04 | $74.92 | |
| Total assets | $228.34 | $256.07 | $238.87 | $297.93 |
| Current liabilities | ||||
| Accounts payable | $1.7 | $0.77 | $2.38 | $1.5 |
| Deferred revenue | $48.38 | $51.74 | ||
| Short long term debt | ||||
| Total current liabilities | $30.82 | $31.39 | $17.14 | $11.43 |
| Long term debt | ||||
| Total noncurrent liabilities | $37.96 | $39.82 | $3.95 | $0.42 |
| Total debt | ||||
| Total liabilities | $68.78 | $71.22 | $21.09 | $11.85 |
| Shareholders' equity | ||||
| Retained earnings | -$401.85 | -$297.15 | -$196.08 | -$110.28 |
| Other shareholder equity | -$0.02 | -$1.18 | -$0.17 | |
| Total shareholder equity | $159.56 | $184.85 | $217.78 | $286.08 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.8 | $3.31 | -$2.48 | $5.15 |
| Cost of revenue | ||||
| Gross Profit | $2.8 | $3.31 | -$2.48 | $5.15 |
| Operating activities | ||||
| Research & development | $21.78 | $20.27 | $20.55 | $19.63 |
| Selling, general & administrative | $10.61 | $10.27 | $10.23 | $10.21 |
| Total operating expenses | $32.39 | $30.54 | $30.78 | $29.84 |
| Operating income | -$29.59 | -$27.23 | -$33.26 | -$24.69 |
| Income from continuing operations | ||||
| EBIT | -$29.55 | -$27.19 | -$33.22 | -$24.65 |
| Income tax expense | ||||
| Interest expense | -$2.59 | -$2.65 | -$2.57 | -$2.1 |
| Net income | ||||
| Net income | -$26.96 | -$24.54 | -$30.65 | -$22.55 |
| Income (for common shares) | -$26.96 | -$24.54 | -$30.65 | -$22.55 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $8.78 | $12.4 | ||
| Cost of revenue | ||||
| Gross Profit | $8.78 | $12.4 | ||
| Operating activities | ||||
| Research & development | $82.23 | $77.84 | $54.17 | $32.2 |
| Selling, general & administrative | $41.32 | $38.92 | $31.9 | $20.85 |
| Total operating expenses | $123.55 | $116.76 | $86.06 | $53.04 |
| Operating income | -$114.77 | -$104.36 | -$86.06 | -$53.04 |
| Income from continuing operations | ||||
| EBIT | -$114.61 | -$104.19 | -$85.69 | -$52.24 |
| Income tax expense | ||||
| Interest expense | -$9.91 | -$3.12 | $0.12 | |
| Net income | ||||
| Net income | -$104.7 | -$101.07 | -$85.81 | -$52.24 |
| Income (for common shares) | -$104.7 | -$101.07 | -$85.81 | -$52.24 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$26.96 | -$24.54 | -$30.65 | -$22.55 |
| Operating activities | ||||
| Depreciation | $1.22 | $1.2 | $1.17 | $1.15 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6.06 | $6.55 | $6.76 | $5.89 |
| Total cash flows from operations | -$20.65 | -$17.26 | -$21.8 | -$21.36 |
| Investing activities | ||||
| Capital expenditures | -$0.23 | -$0.38 | -$0.84 | -$0.17 |
| Investments | $15 | $15 | $24.31 | $53.25 |
| Total cash flows from investing | $14.77 | $14.62 | $23.47 | $53.09 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $7.34 | $0.56 | $0.05 | $45.05 |
| Net borrowings | ||||
| Total cash flows from financing | $7.34 | $0.56 | $0.05 | $45.05 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $1.47 | -$2.08 | $1.72 | $76.78 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$104.7 | -$101.07 | -$85.81 | -$52.24 |
| Operating activities | ||||
| Depreciation | $4.73 | $3.54 | $2.23 | $1.93 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $25.26 | $22.85 | $16.45 | $5.77 |
| Total cash flows from operations | -$81.07 | -$31.87 | -$66.91 | -$42.22 |
| Investing activities | ||||
| Capital expenditures | -$1.62 | -$3.96 | -$1.2 | -$1.05 |
| Investments | $107.56 | -$41.92 | -$75.23 | |
| Total cash flows from investing | $105.95 | -$45.88 | -$76.43 | -$1.05 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $53.01 | $46.41 | $1.29 | $108.59 |
| Net borrowings | ||||
| Total cash flows from financing | $53.01 | $46.41 | $1.28 | $108.11 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $77.89 | -$31.34 | -$142.05 | $64.84 |
News
Fundamentals
| Market cap | $534.95M |
|---|---|
| Enterprise value | $342.94M |
| Shares outstanding | 45.92M |
| Revenue | $8.78M |
|---|---|
| EBITDA | -$109.88M |
| EBIT | -$114.61M |
| Net Income | -$104.70M |
| Revenue Q/Q | -14.26% |
| Revenue Y/Y | -29.21% |
| P/E ratio | -5.11 |
|---|---|
| EV/Sales | 39.05 |
| EV/EBITDA | -3.12 |
| EV/EBIT | -2.99 |
| P/S ratio | 60.92 |
| P/B ratio | 3.35 |
| Book/Share | 3.48 |
| Cash/Share | 4.18 |
| EPS | -$2.28 |
|---|---|
| ROA | -41.59% |
| ROE | -56.86% |
| Debt/Equity | 0.43 |
|---|---|
| Net debt/EBITDA | 1.12 |
| Current ratio | 6.99 |
| Quick ratio | 6.99 |